Inats oxime MCM prod. DEV.

Ended Awarded Last action

Contract number
W911QY18F0701
Awardee
Awarding agency
Obligated
$12,588,258

Award facts

Opportunity
  • W911QY18R0043 Solicitation number
Contract value 89% obligated
$14,177,907.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00022 -$1,427
Funding Only Action P00021 · The objective of this task is to design and conduct nonclinical and clinical research studies. -$22,909
Funding Only Action P00020 · The objectives of this task are to design and conduct nonclinical and clinical research non-GLP/GLP studies, GCP studies and development of cgmp compliant… -$257,815
Other Administrative Action P00019 $400,000
Change Order P00018 · Inats centrally-acting MCM prod. DEV. $1,300,000
Funding Only Action P00017 · Incremental funding for inats centrally-acting MCM prod. DEV. $1,046,301
Supplemental Agreement for work within scope P00016 · Inats centrally-acting MCM prod. DEV. Revising cost and incorporating funding $876,198
Other Administrative Action P00014 · Update with 252.245-7002 reporting loss of government property (deviation 2020-O0004) (FEB 2020) $0
Funding Only Action P00013 · Funding inats centrally-acting MCM prod. DEV. $1,786,610
Other Administrative Action P00012 · Funding for r & d $1,312,247
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 -$779
Other Administrative Action P00008 $779,293
Other Administrative Action P00007 -$2,900,000
Other Administrative Action P00006 -$575,000
Other Administrative Action P00005 -$402,371
Other Administrative Action P00004 $0
Supplemental Agreement for work within scope P00003 · Inats centrally-acting MCM prod. DEV. $8,473,916
Other Administrative Action P00002 $523,111
Other Administrative Action P00001 $0
Original award $250,883
Show all 22

About this award

Battelle Memorial Institute received a $14.2 million cost-plus-fixed-fee delivery order awarded September 27, 2018, under the OASIS (One Acquisition Solution for Integrated Services) multiple award contract vehicle to design and conduct nonclinical and clinical research studies for an Inanitide Oxime (INATS) medical countermeasure. The work, funded by the Joint PEO Chemical and Biological Defense office within the Department of Defense, was performed in Columbus, Ohio, with an ultimate completion date of June 30, 2022. This delivery order represents a significant investment in the development of a potential antidote for chemical weapons exposure, supporting the Defense Department's medical countermeasures portfolio for chemical and biological threats.

The project involved a comprehensive research and development effort with multiple specialized subcontractors supporting distinct work streams. Key subcontractors included Pharmaron CPC for clinical trial execution, Parexel for data management services, Southwest Research Institute for analytical method validation and manufacturing support, Watermark Research Partners for data safety monitoring board services, and CMC Pharmaceuticals for drug formulation development. Additional support was provided by Amplifybio LLC for pharmacokinetic analysis, GXP Quality Systems for biostatistical support, Alcami Corporation for stability testing, Pace Analytical Services for active pharmaceutical ingredient retesting, SIA Partners (Latham Biopharm Group) for medical writing, and Phytex Australia for API manufacturing. This extensive subcontractor network demonstrates the integrated, multi-disciplinary approach required to advance a medical countermeasure from preclinical development through Phase 1 clinical evaluation.

Quick answers

Who was awarded contract W911QY18F0701?

W911QY18F0701 was awarded to Battelle Memorial Institute by ACC Aberdeen Proving Ground (Army Contracting Command) on September 27, 2018.

How much is contract W911QY18F0701 worth?

The government has obligated $12,588,258 on W911QY18F0701. Its current value, with exercised options, is $14,177,907.

Which agency awarded contract W911QY18F0701?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY18F0701, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Is contract W911QY18F0701 an order under another contract?

Yes. W911QY18F0701 is a delivery order under GS00Q14OADU402, an indefinite delivery contract, on One Acquisition Solution for Integrated Services (OASIS).

Was contract W911QY18F0701 competed?

The extent of competition for W911QY18F0701 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award